II. Epidemiology
- Up to 80% of Stimulant Abuse patients obtain medications from family or friends
- Up to 20% abuse their own medications
- Polysubstance abuse with stimulants is common (e.g. Opioids, Benzodiazepines)
III. Causes: Stimulants
- See Stimulant Medication
- Prescribed for Attention Deficit Disorder
- Abused via higher oral dose, or via snorting or injecting the oral medication
- Lower risk of abuse with long acting agents (e.g. Methylphenidate ER) or Lisdexamfetamine (Vyvanse)
- Illicit agents
- Cocaine
- Amphetamine
- Methamphetamine
- Bath Salts
- MDMA
IV. Labs
V. Diagnosis: Stimulant Intoxication (DSM-5)
- Recent use of Amphetamine-like substance, Cocaine or other stimulant agent
- Problem behavioral or pyschological symptoms during or shortly after Stimulant Use (examples follow)
- Euphoria or blunted affect
- Sociability changes
- Hypervigilance
- Interpersonal sensitivity
- Anxiety, tension or anger
- Stereotyped behaviors
- Impaired judgement
- Physical findings that develop during or shortly after Stimulant Use (>=2 of the following)
- Tachycardia or Bradycardia
- Pupilary dilation
- Hypertensive or hypotensive
- Chills or sweats
- Nausea or Vomiting
- Weight loss
- Psychomotor change
- Muscular weakness
- Respiratory depression
- Chest Pain
- Cardiac Arrhythmias
- Confusion
- Seizures
- Involuntary Muscle movements
- Coma
- Findings not attributable to other medical or psychological condition (including other substance Intoxication)
- Modifiers
- Specific intoxicant (e.g. Cocaine, Methamphetamine, bath salts)
- Perceptual disturbance
- Hallucinations with intact reality testing OR
- Auditory, visual or Tactile Hallucinations without Delirium
- References
- (2013) DSM-5, APA
VI. Diagnosis: Stimulant Withdrawal (DSM-5)
- Dysphoric mood AND
- Two or more of the following symptoms developing withing hours to days of stimulant cessation
- Fatigue
- Vivid or unpleasant dreams
- Sleep problems (Insomnia or Hypersomnia)
- Increased appetite
- Psychomotor retardation or Agitation
- References
- (2013) DSM-5, APA
VII. Diagnosis: Stimulant Use Disorder (DSM-5)
- Pattern of Amphetamine-like substance, Cocaine or other stimulant AND
- Use leads to Clinically SignificantImpairment or distress AND
- At least 2 of the following criteria within 12 months
- Stimulant take in larger amounts or over a longer period than intended
- Persistent desire or unsuccessful efforts to cut down or control Stimulant Use
- Significant amount of time spent trying to obtain, use or recover from the stimulant
- Craving or strong desire or urge to use the stimulant
- Recurrent Stimulant Use resulting in failure to fulfill major role obligations at work, school or home
- Use continues despite persistent or recurrent stimulant exacerbated social or interpersonal problems
- Important social, occupational or recreational activities are abandoned or reduced due to Stimulant Use
- Recurrent Stimulant Use in physically hazardous situations
- Use continues despite persistent or recurrent stimulant-related physical or psychological problems
- Tolerance not due to prescribed Stimulant Medication (e.g. Attention Deficit Disorder or Narcolepsy)
- Marked increase in stimulant amounts needed to reach Intoxication or desired effect OR
- Markedly diminished effect with continued use of the same stimulant amount
- Withdrawal not due to prescribed Stimulant Medication (e.g. Attention Deficit Disorder or Narcolepsy)
- Characteristic stimulant withdrawal symptoms (see above) OR
- Stimulant or similar agent is taken to relieve or avoid withdrawal symptoms
- Modifiers
- Early remission
- Following full criteria for Stimulant Use Disorder, no criteria are met for 3-12 months
- Exception: Craving or strong desire or urge for use of stimulant may still be present
- Late remission
- Following full criteria for Stimulant Use Disorder, no criteria are met for >12 months
- Exception: Craving or strong desire or urge for use of stimulant may still be present
- Controlled environment
- Patient is in a controlled environment where stimulant access is restricted
- Early remission
- References
- (2013) DSM-5, APA
VIII. References
- (2023) Presc Lett 30(8): 45-6
- Klega (2018) Am Fam Physician 98(2): 85-92 [PubMed]